dc.contributor.author |
Hlashwayo, Delfina F. |
|
dc.contributor.author |
Sigauque, Betuel |
|
dc.contributor.author |
Noormahomed, Emılia V. |
|
dc.contributor.author |
Afonso, Sonia M. S. |
|
dc.contributor.author |
Mandomando, Inacio M. |
|
dc.contributor.author |
Bila, Custodio G. Bila |
|
dc.date.accessioned |
2022-08-24T07:53:40Z |
|
dc.date.issued |
2021-01-27 |
|
dc.identifier.citation |
Hlashwayo DF, Sigau´que B, Noormahomed EV, Afonso SMS, Mandomando IM, Bila CG (2021) A systematic review and meta analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa. PLoS ONE 16(1): e0245951. |
en_US |
dc.identifier.issn |
e0245951 |
|
dc.identifier.uri |
http://www.repositorio.uem.mz/handle258/694 |
|
dc.description.sponsorship |
The manuscript writing and publication
was supported by the Fogarty International Center
of the National Institutes of Health (Office of the
Director, National Institutes of Health), Eunice
Kennedy Shriver National Institute of Child Health
& Human Development (NICHD) and National
Institute of Neurological Disorders and Stroke |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
PLOS ONE |
en_US |
dc.relation.ispartofseries |
16;1 |
|
dc.rights |
embargoedAcess |
en_US |
dc.subject |
Antibiotic resistance |
en_US |
dc.subject |
Gastroenteritis |
en_US |
dc.subject |
Diarrhea |
en_US |
dc.subject |
HIV |
en_US |
dc.title |
A systematic review and meta-analysis reveal that campylobacter spp. and antibiotic resistance are widespread in humans in subSaharan Africa |
en_US |
dc.type |
article |
en_US |
dc.description.embargo |
2024-01-10 |
|
dc.description.resumo |
Campylobacter spp. are zoonotic bacteria that cause gastroenteritis in humans worldwide,
whose main symptom is diarrhea. In certain cases, extra intestinal manifestations may
occur, such as Guillain Barre´ syndrome. The bacteria cause severe diarrhea mostly in chil dren and in immunocompromised individuals. This review aims to address the prevalence of
Campylobacter spp. in humans in sub-Saharan Africa. It also aims to understand the impact
of HIV in the prevalence, as well as to report data on antibiotic resistance and propose
research priorities.
Methods
We followed PRISMA guidelines to find studies on the occurrence of Campylobacter spp. in
humans in all countries from sub-Saharan Africa. Studies published between 2000 and
2020 were searched in PubMed, Cochrane Library, CINAHL, African Index Medicus, African
Journals Online, Google Scholar and Science Direct. We have conducted a random-effect
meta-analysis and calculated the proportion of resistant isolates to different antibiotics.
Results and discussion
We found 77 studies that described such occurrence in humans in 20 out of 53 sub-Saharan
African countries. Campylobacter jejuni was the most prevalent species. Pooled prevalence
was 9.9% (CI: 8.4%–11.6%). No major variations within the different sub-regions were
found. Most studies reported Campylobacter spp. as the cause of diarrhea, mainly in chil dren. Some studies reported the bacteria as a possible etiologic agent of acute faralysis and urinary tract infection. Campylobacter spp. presented a higher pooled preva lence in HIV infected patients, although not statistically significant. High proportions of resis tant strains were reported for many antibiotics, including erythromycin and tetracycline.
Conclusion
Campylobacter spp. occur in sub-Saharan Africa, although information is scarce or inexis tent for many countries. Research priorities should include investigation of the understudied
species; extra intestinal manifestations; the impact of HIV infection and associated risk fac tors. Control strategies should be reinforced to contain the spread of this pathogen and drug
resistance. |
en_US |
dc.journal |
PLOS ONE |
en_US |